Introduction: Pelvic floor muscle dysfunctions (PFMD) represent a major public health problem manifesting through lower urinary tract symptoms (LUTS), anorectal and sexual dysfunction in the general female population. A large part of the research published in this subject covers non-cancer patients. Aim: This study aims to verify the prevalence of PFMD in patients diagnosed with cervical cancer (CC). Secondly, it is aimed to verify the presence of a multiprofessional approach before, during and after cancer treatment; to evaluate the reasons for not seeking treatment for PFMD; to evaluate the effect of a pelvic floor muscle training (PFMT) in women with PFMD and to assess quality of life (QoL). Methods: Patients with a diagnosis of CC, of any stage, histology and grade, accompanied by the Oncology Gynecology Service of the Clinic Hospital of Medical School of Ribeirão Preto of University of São Paulo will be studied in the period between 2004 and 2014. For the analysis of the prevalence of PFMD will be applied the Discomfort Questionnaire on the Floor Pelvic (PFDI-20) for evaluation of pelvic organ prolapse (POP) complaints, anorectal symptoms and urinary incontinence, and the Sexual Questionnaire for Urinary Incontinence and Pelvic Organ Prolapse (PISQ-12) for evaluation of sexual function. Both questionnaires have already been validated for the Portuguese language and are specific for women with PFMD. A structured questionnaire developed by the researchers will question the presence of a multiprofessional approach before, during and after cancer treatment. This same structured questionnaire still contains questions that address the possible reasons why patients did not seek specialized treatment for PFMD. The Pelvic Floor Impact Questionnaire (PFIQ-7) will also be applied to assess the impact of PFMD on QoL, daily life activities and emotional health. For the evaluation of global QoL, the EORTC QLQ-C30 questionnaire and its specific module for patients with CC, QLQ-CX24, will be used. All questionnaires proposed will be applied by telephone. Patients evidenced with PFMD through the application of the proposed questionnaires will be invited to participate in a PFMT program, with sessions held once a week with a duration of 45 minutes each during the period of 10 week. The PFMT will be supervised by a single physiotherapist.